A high throughput method for identifying personalized tumor-associated antigens

Area of Science:

• Oncology
• Immunology
• Bioinformatics

Background:

• Circulating autoantibodies against tumor-associated antigens (TAAs) and their glycosylation patterns show promise as cancer diagnostic indicators.
• Identifying specific TAAs is crucial for developing effective cancer diagnostics and therapeutics.

Purpose of the Study:

• To develop and validate a method for identifying patient-specific tumor-associated antigens (TAAs) using serum autoantibodies.
• To confirm the tumor specificity of identified TAAs through gene expression analysis.

Main Methods:

• Random peptide library screening of colon cancer patient serum IgG and IgM antibodies.
• BLAST homology searching of identified peptides to identify potential TAAs.
• Statistical analysis of BLAST results to determine significant protein targets.
• Quantitative real-time PCR to analyze mRNA expression of identified TAAs in tumor versus normal samples.

Main Results:

• Patient-specific peptides recognized by serum antibodies were identified.
• A strategy for analyzing BLAST search results successfully identified TAAs mimicking sequential epitopes.
• Statistical analysis and mRNA expression data confirmed the identified proteins as genuine tumor targets.
• Over-expression of the identified TAA's mRNA was observed in corresponding tumor samples.

Conclusions:

• Personalized tumor-associated antigens (TAAs) can be effectively identified using random peptide library screening combined with BLAST homology search.
• This approach offers a novel strategy for discovering cancer-specific biomarkers.
• The findings support the potential of autoantibody profiling for personalized cancer diagnostics.